Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: A longitudinal study

Journal of Affective Disorders

Volumn 83, Issue 2-3, 2004, Pages 183-190

  Bauer, Michael ^a,b   Fairbanks, Lynn ^b   Berghöfer, Anne ^a   Hierholzer, Johannes ^a   Bschor, Tom ^c   Baethge, Christopher ^d   Rasgon, Natalie ^e   Sasse, Johanna ^a   Whybrow, Peter C ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Affective disorders; Bone mineral density; Dual energy X ray absorptiometry; DXA; l thyroxine; Supraphysiological doses

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG MEGADOSE; DRUG RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FOLLOW UP; HORMONE INHIBITION; HUMAN; LINEAR REGRESSION ANALYSIS; LONG TERM CARE; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MALE; MOOD DISORDER; OSTEOLYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPINE; TREATMENT OUTCOME;

ADULT; BIPOLAR DISORDER; BONE DENSITY; DENSITOMETRY, X-RAY; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; THYROXINE;

EID: 8844225680     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2004.08.011     Document Type: Article

References (26)

1. J.E. Adams Single and dual energy X-ray absorptiometry Eur. Radiol. 7 Suppl. 2 1997 S20 S31
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 3rd edition-revised (DSM-III-R) 1987 American Psychiatric Association Washington, DC
3. R. Aronson, H.J. Offman, R.T. Joffe, and D. Naylor Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis Arch. Gen. Psychiatry 53 1996 842 848
4. Baran, D.T., 2000. The skeletal system in thyrotoxicosis. In: Braverman, L.E., Utiger, R.D. (Eds.). The Thyroid. A Fundamental and Clinical Text, 8th ed. Raven, Philadelphia: Lippincott, pp. 659-666.
5. M.S. Bauer, and P.C. Whybrow Rapid cycling bipolar affective disorder. II: treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study Arch. Gen. Psychiatry 47 1990 435 440
6. M. Bauer, and P.C. Whybrow Thyroid hormone, neural tissue and mood modulation World J. Biol. Psychiatr. 2 2001 57 67
7. M. Bauer, R. Hellweg, K.J. Graf, and A. Baumgartner Treatment of refractory depression with high-dose thyroxine Neuropsychopharmacology 18 1998 444 455
8. M. Bauer, S. Priebe, A. Berghöfer, T. Bschor, K. Kiesslinger, and P.C. Whybrow Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders J. Affect. Disord. 64 2001 35 42
9. M. Bauer, A. Berghöfer, T. Bschor, A. Baumgartner, U. Kiesslinger, R. Hellweg, M. Adli, C. Baethge, and B. Müller-Oerlinghausen Supraphysiological doses of thyroxine in the maintenance treatment of prophylaxis resistant affective disorders Neuropsychopharmacology 27 2002 620 628
10. M. Bauer, M. Adli, T. Bschor, A. Heinz, N. Rasgon, M. Frye, H. Grunze, R. Kupka, and P.C. Whybrow Clinical applications of levothyroxine in refractory mood disorders Clin. Appl. Bipolar Disord. 2 2003 49 56
11. A. Baumgartner, M. Bauer, and R. Hellweg Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial Neuropsychopharmacology 10 1994 183 189
12. J. Faber, and A.M. Galloe Changes in bone mass during prolonged subclinical hyperthyroidism due to l-thyroxine treatment: a meta-analysis Eur. J. Endocrinol. 130 1994 350 356
13. J. Franklyn, J. Betteridge, R. Holder, J. Daykin, J. Lilley, and M. Sheppard Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis Clin. Endocrinol. 41 1994 425 432
14. P.W. Gold, F.K. Goodwin, and G.P. Chrousos Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) N. Engl. J. Med. 319 1988 413 420
15. S.L. Greenspan, and F.S. Greenspan The effect of thyroid hormone on skeletal integrity Ann. Intern. Med. 130 1999 750 758
16. S.L. Greenspan, F.S. Greenspan, N.M. Resnick, J.E. Block, A.L. Friedlander, and H.K. Genant Skeletal integrity in premenopausal and postmenopausal women receiving long-term l-thyroxine therapy Am. J. Med. 91 1991 5 14
17. A. Gürlek, and O. Gedik Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women Thyroid 9 1999 539 543
18. L. Gyulai, J. Jaggi, M.S. Bauer, S. Younkin, L. Rubin, M. Attie, and P.C. Whybrow Bone mineral density and l-thyroxine treatment in rapidly cycling bipolar disorder Biol. Psychiatry 41 1997 503 506
19. L. Gyulai, M. Bauer, F. Espana-Garcia, J. Hierholzer, A. Baumgartner, A. Berghöfer, and P.C. Whybrow Bone mineral density in pre- and post-menopausal women with affective disorder treated with long-term l-thyroxine augmentation J. Affect. Disord. 66 2001 185 191
20. L. Lenchik, P. Rochmis, and D.J. Sartoris Optimized interpretation and reporting of dual X-ray absorptiometry (DXA) scans Am. J. Roentgenol. 171 1998 1509 1520
21. Lunar Corporation Technical Manual. Documentation Version 7/91. DPX-L Software Version 1.2 1991 Lunar Corporation Madison, Wisconsin
22. D. Michelson, C. Stratakis, L. Hill, J. Reynolds, E. Galliven, G. Chrousos, and P. Gold Bone mineral density in women with depression N. Engl. J. Med. 335 1996 1176 1181
23. P.D. Miller, S.L. Bonnick, and C.J. Rosen Consensus of an international panel on the clinical utility of bone mass measurements in the detection of low bone mass in the adult population Calcif. Tissue Int. 58 1996 207 214
24. L. Mosekilde, E.F. Eriksen, and P. Charles Effects of thyroid hormones on bone and mineral metabolism Endocrinol. Metab. Clin. N. Am. 19 1990 35 63
25. H.C. Stancer, and E. Persad Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine Arch. Gen. Psychiatry 39 1982 311 312
26. B. Uzzan, J. Campos, M. Cucherat, P. Nony, J.P. Boissel, and G.Y. Perret Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis J. Clin. Endocrinol. Metab. 81 1996 4278 4289